Intercellular transfer of the oncogenic receptor EGFrvIII by microvesicles derived from tumour cells
Intercellular transfer of the oncogenic receptor EGFrvIII by microvesicles derived from tumour cells
复制标题
DOI:
10.1038/ncb1725
复制
发表时间:
2008-05-01
影响因子:
21.3
通讯作者:
Rak, Janusz
中科院分区:
文献类型:
--
作者:
Al-Nedawi, Khalid;Meehan, Brian;Rak, Janusz
Aggressive human brain tumours ( gliomas) often express a truncated and oncogenic form of the epidermal growth factor receptor, known as EGFRvIII. Within each tumour only a small percentage of glioma cells may actually express EGFRvIII; however, most of the cells exhibit a transformed phenotype(1). Here we show that EGFRvIII can be 'shared' between glioma cells by intercellular transfer of membrane-derived microvesicles ('oncosomes'). EGFRvIII expression in indolent glioma cells stimulates formation of lipid-raft related microvesicles containing EGFRvIII. Microvesicles containing this receptor are then released to cellular surroundings and blood of tumour-bearing mice, and can merge with the plasma membranes of cancer cells lacking EGFRvIII. This event leads to the transfer of oncogenic activity, including activation of transforming signalling pathways ( MAPK and Akt), changes in expression of EGFRvIII-regulated genes (VEGF, Bcl- x(L), p27), morphological transformation and increase in anchorage-independent growth capacity. Thus, membrane microvesicles of cancer cells can contribute to a horizontal propagation of oncogenes and their associated transforming phenotype among subsets of cancer cells.